Actionable insights straight to your inbox

Repros Jumps on Positive Drug Trials

Shares in Texas pharma Repros Therapeutics, Inc. (RPRX) gapped up over 30 percent in early morning trading before settling into gains of just over 10 percent on heavy volume as the day wore on.
June 20 saw one of the biggest sell-offs in recent history on the heels of the Fed’s concerns. So we decided to look at the 10 investments that fared the best in a rough climate. We found five